FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2323271314> ?p ?o ?g. }

• W2323271314 endingPage "404" @default.
• W2323271314 startingPage "398" @default.
• W2323271314 abstract "Neuroinflammation triggered by macrophage infiltration into sites of peripheral nerve injury may result in neuropathic pain. Peroxisome proliferator-activated receptor (PPAR)γ signaling regulates the properties of macrophages. However, the macrophage-mediated effects of PPARγ signaling on neuropathic pain triggered by peripheral inflammation have not been investigated.To evaluate the peripheral effects of PPARγ signaling on tactile allodynia, we administered the blood-brain barrier-impermeant PPARγ agonist, rosiglitazone, after partial sciatic nerve ligation (PSNL) as (1) systemic treatment during different phases of neuropathic pain development, (2) local injection to the PSNL site in the early phase, or (3) peritoneal macrophages pretreated with rosiglitazone transplanted into the PSNL site. In addition, the direct effect of rosiglitazone was evaluated in peritoneal macrophages activated with interferon-γ.Systemic rosiglitazone treatment early in the course of progressive inflammation ameliorated tactile allodynia, macrophage infiltration, and production of proinflammatory mediators including cyclooxygenase-2, inducible nitric oxide synthase, and matrix metalloprotease 9 at the PSNL site. Local injection of rosiglitazone and transplantation of rosiglitazone-treated peritoneal macrophages at the ligation site significantly improved tactile allodynia. In peritoneal macrophages, rosiglitazone down-regulated interferon-γ-induced gene expression of cyclooxygenase-2 and inducible nitric oxide synthase and attenuated the chemotactic response to monocyte chemotactic protein-1.Rosiglitazone treatment in the early phase of neuropathic pain significantly alleviated the development of tactile allodynia by regulating macrophage infiltration and production of proinflammatory molecules at the inflamed site. Our results indicate that the activation of PPARγ signaling in macrophages during the early phase may suppress neuropathic pain development." @default.
• W2323271314 created "2016-06-24" @default.
• W2323271314 creator A5032121633 @default.
• W2323271314 creator A5049963649 @default.
• W2323271314 creator A5052460263 @default.
• W2323271314 creator A5069750933 @default.
• W2323271314 date "2011-08-01" @default.
• W2323271314 modified "2023-10-16" @default.
• W2323271314 title "The Macrophage-Mediated Effects of the Peroxisome Proliferator-Activated Receptor-Gamma Agonist Rosiglitazone Attenuate Tactile Allodynia in the Early Phase of Neuropathic Pain Development" @default.
• W2323271314 cites W1633340712 @default.
• W2323271314 cites W1998933601 @default.
• W2323271314 cites W2000814289 @default.
• W2323271314 cites W2004460437 @default.
• W2323271314 cites W2004478056 @default.
• W2323271314 cites W2012650972 @default.
• W2323271314 cites W2016989056 @default.
• W2323271314 cites W2020939052 @default.
• W2323271314 cites W2023459898 @default.
• W2323271314 cites W2027363457 @default.
• W2323271314 cites W2032563782 @default.
• W2323271314 cites W2047852384 @default.
• W2323271314 cites W2054472394 @default.
• W2323271314 cites W2065432788 @default.
• W2323271314 cites W2065765759 @default.
• W2323271314 cites W2066704041 @default.
• W2323271314 cites W2067924690 @default.
• W2323271314 cites W2075715972 @default.
• W2323271314 cites W2077885131 @default.
• W2323271314 cites W2080932190 @default.
• W2323271314 cites W2091142824 @default.
• W2323271314 cites W2095013915 @default.
• W2323271314 cites W2100604698 @default.
• W2323271314 cites W2102628016 @default.
• W2323271314 cites W2103351070 @default.
• W2323271314 cites W2110769281 @default.
• W2323271314 cites W2117567240 @default.
• W2323271314 cites W2118207479 @default.
• W2323271314 cites W2118738332 @default.
• W2323271314 cites W2134916859 @default.
• W2323271314 cites W2149599746 @default.
• W2323271314 cites W2168374306 @default.
• W2323271314 cites W2172201406 @default.
• W2323271314 doi "https://doi.org/10.1213/ane.0b013e31821b220c" @default.
• W2323271314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21490083" @default.
• W2323271314 hasPublicationYear "2011" @default.
• W2323271314 type Work @default.
• W2323271314 sameAs 2323271314 @default.
• W2323271314 citedByCount "40" @default.
• W2323271314 countsByYear W23232713142012 @default.
• W2323271314 countsByYear W23232713142013 @default.
• W2323271314 countsByYear W23232713142014 @default.
• W2323271314 countsByYear W23232713142015 @default.
• W2323271314 countsByYear W23232713142016 @default.
• W2323271314 countsByYear W23232713142017 @default.
• W2323271314 countsByYear W23232713142018 @default.
• W2323271314 countsByYear W23232713142019 @default.
• W2323271314 countsByYear W23232713142020 @default.
• W2323271314 countsByYear W23232713142021 @default.
• W2323271314 countsByYear W23232713142022 @default.
• W2323271314 countsByYear W23232713142023 @default.
• W2323271314 crossrefType "journal-article" @default.
• W2323271314 hasAuthorship W2323271314A5032121633 @default.
• W2323271314 hasAuthorship W2323271314A5049963649 @default.
• W2323271314 hasAuthorship W2323271314A5052460263 @default.
• W2323271314 hasAuthorship W2323271314A5069750933 @default.
• W2323271314 hasBestOaLocation W23232713141 @default.
• W2323271314 hasConcept C126322002 @default.
• W2323271314 hasConcept C134018914 @default.
• W2323271314 hasConcept C15490471 @default.
• W2323271314 hasConcept C164027704 @default.
• W2323271314 hasConcept C170493617 @default.
• W2323271314 hasConcept C2776914184 @default.
• W2323271314 hasConcept C2777107010 @default.
• W2323271314 hasConcept C2777883359 @default.
• W2323271314 hasConcept C2779245659 @default.
• W2323271314 hasConcept C2780152017 @default.
• W2323271314 hasConcept C71924100 @default.
• W2323271314 hasConcept C98274493 @default.
• W2323271314 hasConceptScore W2323271314C126322002 @default.
• W2323271314 hasConceptScore W2323271314C134018914 @default.
• W2323271314 hasConceptScore W2323271314C15490471 @default.
• W2323271314 hasConceptScore W2323271314C164027704 @default.
• W2323271314 hasConceptScore W2323271314C170493617 @default.
• W2323271314 hasConceptScore W2323271314C2776914184 @default.
• W2323271314 hasConceptScore W2323271314C2777107010 @default.
• W2323271314 hasConceptScore W2323271314C2777883359 @default.
• W2323271314 hasConceptScore W2323271314C2779245659 @default.
• W2323271314 hasConceptScore W2323271314C2780152017 @default.
• W2323271314 hasConceptScore W2323271314C71924100 @default.
• W2323271314 hasConceptScore W2323271314C98274493 @default.
• W2323271314 hasIssue "2" @default.
• W2323271314 hasLocation W23232713141 @default.
• W2323271314 hasLocation W23232713142 @default.
• W2323271314 hasLocation W23232713143 @default.
• W2323271314 hasOpenAccess W2323271314 @default.
• W2323271314 hasPrimaryLocation W23232713141 @default.
• W2323271314 hasRelatedWork W1965765907 @default.
• W2323271314 hasRelatedWork W2014113220 @default.

• next